sensit
report
assay
measur
human
immunodefici
viru
type
proteas
pr
activ
describ
manuscript
assay
measur
pr
activ
function
reson
energi
transfer
ret
donour
molecul
human
sea
pansi
renilla
reniformi
luciferas
hrluc
energi
acceptor
molecul
human
green
fluoresc
protein
express
mammalian
cell
natur
occur
phenomenon
emerg
power
technolog
signific
advantag
altern
vitro
pr
assay
pr
site
insert
hrluc
newli
creat
vector
coexpress
codonoptim
pr
gagpol
expressor
express
alon
gagpol
expressor
gener
indic
pr
cleavag
site
cleav
wherea
inclus
pr
gagpol
produc
signific
reduct
inclus
pr
inhibitor
saquinavir
amprenavir
express
pr
substrat
mutant
also
block
cleavag
result
stabl
signal
auxiliari
protein
vif
shown
modul
cleavag
assay
valid
studi
vif
express
vif
overexpress
along
pr
gagpol
decreas
abrog
dosedepend
manner
demonstr
supraphysiolog
level
vif
block
cleavag
accumul
gag
process
intermedi
observ
indic
cleavag
neg
affect
overexpress
rnabindingdefect
staufen
protein
relat
dsrnabind
protein
trbp
effect
pr
cleavag
activ
shown
western
analys
process
data
confirm
western
blot
analys
bret
noninvas
occur
within
live
cell
measur
real
time
restrict
cellular
compart
make
especi
attract
technolog
identifi
small
bioactiv
inhibitori
molecul
pr
biosensor
assay
adapt
high
throughput
screen
new
pr
inhibitor
employ
screen
antivir
compound
also
target
proteas
virus
current
approv
drug
use
antivir
upward
least
new
antivir
therapi
clinic
trial
around
world
pharmaceut
research
manufactur
america
de
clercq
new
improv
inhibitor
pr
introduct
first
pr
inhibitor
character
excit
hope
control
infect
sinc
infect
individu
rapidli
becom
resist
antipr
drug
need
identifi
new
inhibitor
becam
appar
wherea
current
methodolog
screen
compound
base
larg
electrophoresi
liquid
chromatographi
method
clear
addit
screen
assay
also
need
respond
demand
would
ideal
rapid
capabl
high
throughput
screen
ht
procedur
initi
effort
use
fluorogen
fluoresc
quench
substrat
proteolysi
enabl
higher
throughput
screen
antipr
compound
could
readili
adapt
ht
matayoshi
et
al
mcquad
et
al
recent
effort
use
ident
chemistri
edan
dabcyl
continu
use
develop
high
throughput
micropl
assay
bagossi
et
al
screen
assay
antipr
drug
reli
vitro
analysi
inhibit
certain
biochem
reaction
result
product
assay
intermedi
metabolit
vitro
estim
gener
follow
detail
pharmacolog
test
pharmacolog
screen
variou
vitro
vivo
assay
assay
howev
nonhomogen
requir
synthet
substrat
execut
entir
vitro
condit
purifi
protein
baruch
et
al
ideal
initi
screen
assay
close
physiolog
condit
possibl
even
better
homogen
assay
test
inhibit
pr
live
cell
report
highli
sensit
biosensor
assay
use
identifi
pr
inhibitor
describ
base
bioluminesc
reson
energi
transfer
second
gener
natur
occur
phenomenon
reli
reson
energi
transfer
ret
donour
hrluc
acceptor
molecul
ret
initi
addit
deepblu
c
coelenterazin
oxid
rluc
result
emiss
light
nm
part
energi
transfer
nonradi
codonoptim
human
hrluc
close
proxim
forster
distanc
emit
light
nm
emiss
quantit
sequenti
read
use
combin
luminomet
fluoresc
plate
reader
emiss
spectra
suffici
distinct
allow
straightforward
ratiometr
analysi
hrluc
signal
assess
molecular
interact
proxim
hrluc
live
cell
emerg
power
technolog
signific
advantag
altern
vitro
approach
baruch
et
al
exampl
noninvas
occur
within
live
cell
measur
real
time
restrict
cellular
compart
make
especi
attract
identifi
small
bioactiv
inhibitori
molecul
use
studi
proteinprotein
interact
posttransl
modif
protein
live
cell
anger
et
al
bertrand
et
al
germaindesprez
et
al
issafra
et
al
perroy
et
al
assay
describ
util
new
technolog
assay
pr
inhibit
live
cell
specif
util
establish
pr
biosensor
assay
demonstr
assay
valid
use
sever
known
pr
inhibitor
moreov
virushost
interact
also
critic
step
viral
replic
cycl
assay
also
use
probe
function
viral
protein
modul
pr
activ
may
help
elucid
molecular
detail
pr
function
matur
pr
activ
highli
regul
time
wellcharacter
cleavag
order
pettit
et
al
sever
factor
rna
viral
protein
host
protein
demonstr
impact
pr
activ
guo
et
al
sheng
ericksonviitanen
sheng
et
al
zhang
barkli
furthermor
small
molecul
compound
identifi
recent
act
select
proteas
site
delay
matur
precursor
gag
protein
zhou
et
al
interest
futur
identifi
antivir
compound
target
pr
identifi
small
molecul
could
block
pr
cleavag
select
inhibit
cleavag
particular
site
zhou
et
al
pr
biosensor
assay
base
describ
manuscript
assay
valid
use
commerci
avail
pr
inhibitor
auxiliari
protein
vif
steric
inhibit
pr
function
gag
site
assay
valid
cell
use
inform
pr
biosensor
assay
sensit
provid
measur
absolut
pr
activ
live
cell
assay
employ
screen
new
pr
inhibitor
modifi
enabl
ht
librari
small
molecul
inhibit
pr
activ
later
step
viru
matur
obtain
perkinelmerpackard
bioscienc
montreal
pq
harbour
multipl
clone
site
rluc
open
read
frame
engin
allow
insert
code
sequenc
infram
two
gene
gagpol
express
vector
pr
due
point
mutat
pr
activ
site
report
elsewher
huang
et
al
huang
et
al
mammalian
express
vector
staufen
tarrna
bind
protein
trbp
vif
codonoptim
express
vector
allow
highlevel
express
without
requir
rev
express
report
elsewher
chatelchaix
et
al
mouland
et
al
nguyen
et
al
set
complementari
dna
oligom
alphadna
montreal
quebec
encod
indic
pr
cleavag
site
amino
acid
either
side
present
tabl
set
oligonucleotid
design
direct
clone
infram
hrluc
open
read
frame
psti
kpni
site
psti
site
engin
destroy
allow
screen
pr
cleavag
site
introduc
addit
construct
design
contain
random
mutat
pr
cleavag
site
prevent
recognit
cleavag
pr
fig
construct
contain
pr
substrat
gener
well
construct
extend
site
five
amino
acid
side
sinc
origin
pr
substrat
incap
cleav
assay
data
shown
parent
construct
linear
digest
psti
kpni
gelpurifi
use
qiaquick
gel
purif
kit
qiagen
hybrid
oligonucleotid
introduc
standard
ligat
procedur
use
optim
ratio
oligonucleotid
duplex
clone
verifi
dideoxynucleotid
sequenc
analysi
amersham
transient
express
analys
cell
human
embryon
kidney
hek
cell
cultur
dulbecco
modifi
eagl
medium
addit
fetal
bovin
serum
penicillinstreptomycin
invitrogen
cell
minim
passag
order
maintain
high
transfect
effici
cell
plate
nunc
plate
approxim
cellswel
cell
incub
overnight
antibioticfre
dmem
supplement
fb
transfect
optim
amount
dna
transfect
determin
g
g
gagpol
expressor
huang
et
al
vector
x
pr
cleavag
site
maximum
g
dnawel
lipofectamin
invitrogen
use
essenti
accord
manufactur
instruct
l
lipofectamineg
dna
ratio
fbsand
antibioticfre
dmem
posttransfect
medium
cell
replac
fresh
dmem
contain
fb
cell
collect
h
posttransfect
ml
phosphatebuff
salin
contain
mm
edta
centrifug
g
min
c
cell
resuspend
pb
final
concentr
cellsml
experi
vif
overexpress
codonoptim
vif
expressor
use
nguyen
et
al
quantiti
dna
transfect
g
well
amount
lipofectamin
adjust
accordingli
viral
cellular
protein
coexpress
hrluc
measur
calcul
ratio
perform
essenti
describ
previous
germaindesprez
et
al
mercier
et
al
modif
adapt
use
detect
instrument
follow
l
cell
suspens
cell
aliquot
well
white
opaqu
flatbottom
micropl
perkinelm
life
scienc
deepbluec
coelenterazin
biopackardsign
montreal
pq
cell
permeant
luciferas
substrat
ad
well
obtain
final
concentr
immedi
follow
addit
five
read
hrluc
sequenti
record
use
fusion
apparatu
perkinelmercanberra
packard
first
light
emit
bioluminesc
result
rlucmedi
coelenterazin
degrad
nm
band
pass
nm
detect
emiss
peak
nm
detect
use
nm
filter
band
pass
nm
read
analysi
top
plate
ratio
found
stabl
sever
read
perform
differ
time
addit
substrat
evalu
within
min
express
level
non
retinduc
hrluc
experiment
condit
determin
direct
measur
total
luminesc
level
aliquot
transfect
cell
sampl
follow
total
fluoresc
measur
fig
gagpol
cleav
viral
pr
gener
matur
portein
indic
scheme
gagpol
deriv
protein
shown
ca
spacer
peptid
nc
spacer
peptid
pr
proteas
rt
revers
transcriptas
h
rnaseh
integras
pr
cleavag
site
locat
gagpol
matur
protein
list
site
locat
nc
scheme
assay
shown
b
describ
text
briefli
addit
deepbluec
coelenterazin
initi
reson
energi
transfer
case
close
physic
interact
context
fusion
protein
step
pr
cleav
substrat
step
distanc
donor
acceptor
molecul
therebi
lower
ret
step
inhibitor
pr
vif
manuscript
pr
inhibitor
use
haart
maintain
signal
pr
activ
inhibit
inset
show
pr
cleavag
site
mutant
site
introduc
donor
acceptor
molecul
test
report
letter
code
amino
acid
indic
use
fusion
apparatu
perkinelmercanberrapackard
excit
filter
nm
emiss
filter
nm
follow
paramet
gain
pmt
v
time
fluoresc
measur
cell
incub
min
coelenterazin
h
molecular
probe
final
concentr
total
luminesc
cell
measur
use
instrument
set
bioluminesc
read
follow
paramet
gain
pmt
v
time
contrast
deepblu
c
coelenterazin
coelenterazin
h
lead
energi
transfer
thu
allow
assess
hrluc
express
without
loss
due
energi
transfer
express
ratio
total
hrluc
ratio
found
ident
experi
indic
stabl
level
express
protein
median
read
use
calcul
ratio
ratio
quantifi
calcul
retinduc
ratio
ratio
determin
follow
equat
emiss
nmemiss
nm
cell
express
hrluc
fusion
protein
emiss
nmemiss
cell
express
hrluc
alon
chatelchaix
et
al
germaindesprez
et
al
parent
construct
contain
multipl
clone
site
hrluc
cistron
serv
posit
control
follow
measur
cell
centrifug
min
g
lyse
lysi
buffer
mm
nacl
mm
tri
mm
edta
mm
proteas
inhibitor
complet
mini
edtafre
proteas
inhbitor
cocktail
ice
min
cell
lysat
centrifug
g
min
supernat
transfer
new
eppendorf
protein
content
cytosol
extract
quantit
microbradford
assay
gagpol
gag
product
express
assess
western
blot
analys
use
mous
antibodi
gener
provid
dr
grandgenett
aid
research
refer
reagent
program
rabbit
antibodi
abttrin
biotechnolog
ca
usa
catalogu
antigfp
antibodi
rdi
catalogu
vif
staufen
trbp
express
cell
follow
antibodi
use
rabbit
polyclon
antivif
nguyen
et
al
mous
monoclon
antistaufen
gener
provid
l
desgroseil
de
chatelchaix
et
al
rabbit
antitrbp
gener
provid
gatignol
mcgill
univers
mouland
et
al
experi
staufen
overexpress
staufen
identifi
cellular
extract
use
antiha
tag
monoclon
mouland
et
al
antigapdh
antibodi
purchas
rdi
inc
express
use
load
control
chatelchaix
et
al
pr
inhibitor
saquinavir
amprenavir
obtain
divis
aid
nih
nih
aid
research
refer
reagent
program
use
deepblu
c
coelenterazin
purchas
perkinelm
mississauga
coelenterazin
h
molecular
probe
eugen
order
verifi
cell
neg
affect
transfect
condit
use
experi
present
report
cell
cycl
annexin
analys
perform
exactli
describ
mouland
et
al
yao
et
al
nine
pr
substrat
gagpol
polyprotein
fig
process
give
rise
function
matur
gag
protein
assay
develop
identifi
viral
cellular
factor
influenc
pr
activ
sever
pr
site
origin
test
assay
inset
fig
origin
goal
studi
compar
two
proteas
cleavag
site
one
primari
pr
site
process
earli
follow
pr
activ
anoth
secondari
pr
site
process
later
stage
viral
matur
rational
examin
earli
late
event
matur
eventu
develop
high
throughput
screen
compound
small
molecul
viral
cellular
protein
inhibit
either
cleavag
reaction
howev
site
amen
cleavag
coexpress
pr
site
test
pr
substrat
show
variabl
express
level
data
shown
see
section
possibl
pr
cleavag
substrat
short
amino
acid
stretch
perhap
prevent
pr
bind
site
extend
addit
five
amino
acid
end
fig
preliminari
test
show
improv
abil
cleav
data
shown
base
preliminari
find
pr
substrat
site
chosen
subsequ
experiment
therefor
site
insert
frame
hrluc
cistron
shown
red
box
fig
analys
perform
follow
addit
membran
permeabl
hrluc
substrat
deepbluec
coelenterazin
pr
substrat
site
use
subsequ
experiment
includ
site
harbour
three
amino
acid
substitut
cleavag
site
fig
order
verifi
pr
abl
cleav
insert
pr
substrat
cell
transfect
gagpol
pr
express
construct
gagpol
vector
express
gag
gagpol
gagpol
express
level
first
verifi
system
cell
mock
transfect
transfect
either
gagpol
pr
h
post
transfect
cellular
cell
process
western
analys
moieti
gener
cleavag
fusion
protein
observ
presenc
pr
gagpol
express
c
addit
pr
inhibitor
amprenavir
saquinavir
inhibit
cleavag
parent
construct
ad
control
extract
prepar
express
pattern
gag
determin
western
blot
analysi
analysi
show
blot
probe
antibodi
recogn
well
matur
gag
protein
express
show
gagpol
polyprotein
detect
kda
gagpol
process
fig
gag
also
detect
process
also
transfect
gagpol
pr
show
effici
process
gagpol
shown
strong
signal
matur
form
gag
next
determin
express
pattern
coexpress
fusion
protein
cell
extract
parent
insert
cell
absenc
top
presenc
bottom
pr
blot
use
antigfp
antiserum
fig
analysi
show
detect
cleavag
parent
fusion
protein
gagpol
express
top
panel
express
pr
mediat
cleavag
fusion
protein
yield
signal
kda
slightli
greater
molecular
weight
signal
express
alon
bottom
panel
result
also
confirm
blot
shown
fig
data
shown
addit
pr
inhibitor
amprenavir
saquinavir
h
cell
harvest
analysi
prevent
cleavag
scissil
bond
pr
express
fig
obtain
ident
express
pattern
obtain
parent
vector
gag
gagpol
process
determin
use
antiserum
western
blot
analysi
analysi
show
gag
process
block
presenc
pr
inhibitor
evidenc
absenc
matur
gag
protein
data
shown
recent
data
demonstr
auxiliari
protein
vif
select
block
process
canc
boundari
steric
interfer
result
accumul
gag
process
intermedi
consist
ca
nc
one
spacer
peptid
recent
data
consid
order
valid
pr
biosensor
assay
use
construct
shown
fig
gagpol
pr
increas
concentr
vif
overexpress
human
vif
express
plasmid
requir
rev
express
nguyen
et
al
result
detect
increas
vif
express
cell
increas
dna
transfect
fig
top
panel
supraphysiolog
express
vif
inhibit
cleavag
indic
dosedepend
accumul
fusion
protein
diminish
abund
moieti
fig
middl
panel
furthermor
use
antinc
gener
provid
dr
robert
gorelick
accumul
one
gag
process
intermedi
identifi
western
blot
like
fig
top
vif
express
shown
earlier
work
show
vif
mediat
accumul
gag
process
intermedi
context
provir
gene
express
one
immunoreact
gag
process
intermedi
detect
may
due
condit
gagpol
pr
express
use
manuscript
low
abund
gag
speci
analys
perform
describ
section
post
transfect
result
present
fig
ratio
direct
measur
degre
cleav
coexpress
fig
analys
cell
mock
transfect
cotransfect
gagpol
pr
gagpol
increas
concentr
g
vif
expressor
includ
gagpol
pr
last
three
lane
cell
harvest
blot
gag
shown
overexpress
vif
caus
dosedepend
accumul
fusion
protein
precursor
indic
inhibit
vif
pr
activ
site
vif
express
inhibit
pr
activ
determin
see
b
almost
obtain
context
b
cell
transfect
except
sever
control
includ
hrluc
express
alon
transfect
condit
indic
histogram
threshold
valu
shown
dash
line
error
bar
repres
mean
sem
least
five
independ
experi
except
last
two
condit
staufen
doubl
strand
rnabind
mutant
protein
dsrbdmut
trbp
protein
express
g
error
bar
repres
standard
deviat
calcul
two
independ
experi
gagpol
pr
ratio
determin
cell
mocktransfect
transfect
hrluc
alon
experi
presenc
pr
express
signal
control
transfect
condit
fig
express
absenc
pr
ie
context
gagpol
show
strong
signal
similar
level
found
cell
treat
saquinavir
without
pr
amprenavir
nelfinavir
data
shown
transfect
parent
construct
pr
cleavag
site
pr
effici
cleav
presenc
pr
mutant
harbour
three
amino
acid
substitut
fig
cleav
analys
perform
experi
vif
overexpress
vif
increment
overexpress
cell
fig
analys
reveal
vif
inhibitori
cleavag
reflect
dosedepend
increas
reach
obtain
data
fig
might
suggest
overexpress
protein
decreas
pr
activ
nonspecif
thu
order
rule
either
doublestrand
rna
bind
mutant
dsrbdmut
form
staufen
relat
dsrnabind
protein
trbp
express
control
analys
increas
express
protein
achiev
determin
western
blot
analys
data
shown
overexpress
protein
result
constant
ratio
impact
pr
activ
cleavag
pr
site
overexpress
result
indic
vif
effect
pr
action
select
histogram
present
fig
express
calcul
averag
analys
least
five
experi
per
experiment
condit
express
pr
associ
apoptosi
cell
cycl
express
strack
et
al
wallin
et
al
shoeman
et
al
cell
cycl
apoptosi
annexin
analys
perform
use
fac
analys
reveal
effect
pr
express
cell
cycl
apoptosi
level
use
transient
condit
describ
assay
shown
perhap
pr
express
precursor
protein
context
alreadi
shown
prevent
cytotox
pr
lindsten
et
al
data
shown
report
describ
novel
biosensor
assay
pr
activ
assay
homogen
perform
live
cell
need
prepar
cell
extract
simpl
addit
membranediffus
nontox
substrat
initi
biochem
reaction
requir
readout
retinduc
emiss
readili
detect
fluoresc
plate
reader
fig
assay
also
reli
straightforward
ratiometr
calcul
light
emit
caus
interact
hrluc
substrat
result
emiss
case
ret
two
protein
experiment
system
first
test
use
bicistron
construct
pr
background
result
demonstr
appropri
gag
process
pr
specif
cleavag
result
decreas
ratio
pr
context
fig
mutat
pr
substrat
introduc
hrluc
open
read
frame
altern
potent
antipr
drug
amprenavir
saquinavir
employ
block
pr
activ
cell
control
experi
demonstr
sensit
approach
repres
first
valid
experi
one
aim
studi
test
pr
site
cleav
earli
eg
matur
one
cleav
late
eg
inabl
effici
cleav
site
even
extend
pr
substrat
fig
suggest
site
must
contextu
correct
state
substrat
pr
appear
case
cleavag
howev
sinc
cleav
effici
minim
context
fig
nevertheless
site
estim
cleav
pettit
et
al
determin
requir
recapitul
experiment
system
use
previou
report
demonstr
correct
gagpol
dimeris
necessari
proper
assembl
altern
factor
includ
viral
protein
context
assembl
bud
presenc
genom
rna
shown
import
retrovir
pr
might
also
influenc
context
sheng
ericksonviitanen
sheng
et
al
zhang
et
al
zhang
barkli
noteworthi
earlier
report
fluorescencebas
pr
vitro
screen
assay
never
employ
gag
pr
site
indic
may
amen
type
analysi
wherea
assay
use
pr
cleavag
site
vitro
pr
assay
small
peptid
substrat
employ
express
construct
prepar
low
employ
studi
kh
ajm
data
shown
reconstitut
miss
factor
may
help
identif
select
pr
inhibitor
site
recent
result
demonstr
overexpress
auxiliari
protein
vif
steric
inhibit
process
pr
substrat
site
inform
use
valid
pr
biosensor
assay
describ
report
result
shown
fig
b
confirm
supraphysiolog
express
vif
auxiliari
protein
inhibit
cleavag
result
stabl
signal
vif
overexpress
also
result
accumul
gag
process
intermedi
fig
data
present
consist
earlier
work
provir
gene
express
accumul
gag
process
intermedi
found
vif
overexpress
recent
work
character
import
virushost
interact
lysyl
trna
synthetas
lysr
main
structur
protein
gag
javanbakht
et
al
valu
pr
biosensor
assay
demonstr
recent
identifi
lysr
cellular
mediat
pr
activ
guo
et
al
data
support
notion
lysr
part
gag
assembl
complex
kleiman
cen
dramat
impact
gag
process
matur
impact
vif
viru
matur
deriv
earlier
report
demonstr
vif
associ
gag
bouyac
et
al
genom
rna
zhang
et
al
effect
core
stabil
ohagen
gabuzda
directli
interact
interfer
pr
baraz
et
al
bardi
et
al
final
vif
shown
incorpor
bud
virion
kao
et
al
sever
characterist
share
lysr
vif
vif
howev
shown
select
influenc
cleavag
steric
interfer
lend
idea
may
somehow
regul
time
pr
activ
viral
matur
process
pr
site
also
influenc
genom
rna
dimer
matur
shehuxhilaga
et
al
futur
work
address
viral
cellular
protein
function
coordin
matur
bud
process
bret
first
exploit
studi
dimer
circadian
protein
bacteria
xu
et
al
associ
sevenmembran
span
g
protein
coupl
receptor
coreceptor
cofactor
signal
reaction
anger
et
al
extend
examin
tyrosin
kinas
receptor
activ
bout
et
al
transcript
factor
associ
germaindesprez
et
al
recent
use
sever
studi
virushost
interact
coreceptor
dynam
membran
issafra
et
al
babcock
et
al
chatelchaix
et
al
guo
et
al
percheranci
et
al
recent
work
also
employ
vivo
ubiquitin
assay
perroy
et
al
bret
consid
valuabl
approach
forefront
ht
identifi
new
desper
need
pharmacolog
drug
roda
et
al
small
molecul
inhibitor
target
specif
pr
site
alreadi
identifi
zhou
et
al
assay
report
prove
use
identifi
sequenc
specif
inhibitor
pr
site
live
cell
pr
biosensor
assay
could
also
use
screen
small
molecul
remain
activ
due
drug
resist
mutat
occur
around
pr
site
gag
feher
et
al
final
assay
also
adapt
ht
small
molecul
inhibitor
live
cell
gener
stabl
indic
cell
line
express
necessari
compon
assay
sum
develop
novel
sensit
biosensor
assay
pr
activ
provid
essenti
benefit
report
assay
perform
live
cell
amen
ht
new
compound
without
appar
toxic
assay
also
applic
identif
small
molecul
inhibit
essenti
function
proteas
emerg
virus
like
coronaviru
caus
sever
acut
respiratori
syndrom
sarscov
hepatitu
c
blanchard
et
al
lee
et
al
